title: [Use of the methylxanthines, caffeine and theophylline, in the treatment of extrapyramidal disorders caused by treatment with neuroleptics. Development of a therapeutic hypothesis].
authors.affiliation: Programa Sant Pau-CITRAN, Fundació d'Investigació Santa Creu i Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Espagne.
authors.forename: M
authors.initials: M
authors.lastname: Casas
authors.forename: M
authors.initials: M
authors.lastname: Torrens
authors.forename: P
authors.initials: P
authors.lastname: Duro
authors.forename: C
authors.initials: C
authors.lastname: Pinet
authors.forename: E
authors.initials: E
authors.lastname: Alvarez
authors.forename: C
authors.initials: C
authors.lastname: Udina
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects*; D001480:Basal Ganglia Diseases / Q000139:chemically induced* / Q000188:drug therapy; D002110:Caffeine / Q000627:therapeutic use*; D004298:Dopamine / Q000502:physiology*; D006801:Humans; D013806:Theophylline / Q000627:therapeutic use*
chemical_list: D014150:Antipsychotic Agents; D002110:Caffeine; D013806:Theophylline; D004298:Dopamine
vernacular_title: Utilisation des méthylxanthines, caféine et théophylline dans le traitement des troubles extrapyramidaux secondaires aux traitements par les neuroleptiques. Déroulement d'une hypothèse thérapeutique.